Anirban Maitra: Amazing combo ICI results but an unfair comparator arm
Anirban Maitra, Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center, shared a paper by Thierry Andre et al. on X:
“Amazing combo ICI results but an unfair comparator arm. The whole point I run IHCs for MMR proteins in every single newly diagnosed colorectal cancer biopsy is to avoid the comparator arm here. I don’t get it. But I am just the GI pathologist here.”
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
Authors: Thierry Andre, M.D., Elena Elez, M.D., Ph.D., Eric Van Cutsem, M.D., Ph.D., Lars Henrik Jensen, M.D., Ph.D., Jaafar Bennouna, M.D., Ph.D., Guillermo Mendez, M.D., Michael Schenker, M.D., Ph.D., +20, for the CheckMate 8HW Investigator
Dr. Anirban Maitra serves as Professor of Pathology and Translational Molecular Pathology at UT MD Anderson Cancer Center since August 2013, and directs the Sheikh Ahmed Pancreatic Cancer Research Center. He leads an NCI-funded laboratory dedicated to pancreatic cancer research, focusing on genetics and molecular pathology in human and mouse models. His research aims to advance early detection and interception strategies to enhance patient survival rates in pancreatic cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023